← Back to Patent Explorer
US5922597A Expired / Lapsed US ⏱️ 0.0 years remaining

Ex vivo culture of stem cells

Assignee: University of Minnesota System
•
Filing: 1996-11-13
•
Granted: 1999-07-13
•
Expires: 2016-11-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract PCT No. PCT/US96/18222 Sec. 371 Date Jul. 14, 1997 Sec. 102(e) Date Jul. 14, 1997 PCT Filed Nov. 13, 1996 PCT Pub. No. WO97/18298 PCT Pub. Date May 22, 1997A method for the culture of hematopoietic cells is provided comprising culturing said cells in stromal conditioned medium comprising one or more cytokines selected from the group consisting of MIP-1 alpha , IL-3, SCF, BB10010 and PF-4, so that the ability of the stem cells to self-replicate and differentiate is maintained or the ability of the committed progenitors to expand and differentiate is maintained.

Inventors

  • 👤 Catherine M. Verfaillie
  • 👤 Philip B. McGlave
  • 👤 Jeffrey S. Miller

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 09:39
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0634; C12N5/0646; A; A61; A61K; A61K40/00; A61K40/10; A61K40/15; A61K40/40; A61K40/41; A61K40/42; C12N5/0647; A61K35/00; A61K35/12; A61K2035/124; C12N2500/00; C12N2500/30; C12N2500/38; C12N2501/00; C12N2501/10; C12N2501/125; C12N2501/20; C12N2501/21; C12N2501/23; C12N2501/30; C12N2501/38; C12N2501/39; C12N2502/00; C12N2502/13; C12N2502/1394

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 84 words
A method for culturing hematopoietic cells, comprising: culturing a population of human hematopoietic cells comprising stem cells or committed progenitor cells in a stromal conditioned medium in the absence of stromal cells, wherein the medium comprises an effective added amount of one or more cytokines selected from the group consisting of MIP-1α, IL-3, SCF, BB10010 and PF-4, so that the ability of the stem cells to self-replicate and differentiate is maintained or the ability of the committed progenitors to expand and differentiate is maintained.
Claim 2
Independent Claim 84 words
A method for culturing hematopoietic cells, comprising: culturing a population of human hematopoietic cells comprising stem cells or committed progenitor cells in a stromal conditioned medium in the absence of stromal cells, wherein the medium comprises an effective added amount of one or more cytokines selected from the group consisting of MIP-1α, IL-3, SCF, BB10010 and PF-4, so that the ability of the stem cells to self-replicate and differentiate is maintained or the ability of the committed progenitors to expand and differentiate is maintained.
Claim 3
Dependent Claim 15 words
The method of claim 1 wherein the hematopoietic cells consist essentially of committed progenitor cells.
Claim 4
Dependent Claim 12 words
The method of claim 1 wherein the hematopoietic cells comprise stem cells.
Claim 5
Dependent Claim 15 words
The method of claim 1 wherein the hematopoietic cells are derived from bone marrow cells.
Claim 6
Dependent Claim 16 words
The method of claim 1 wherein the hematopoietic cells are chronic myelogenous leukemia bone marrow cells.
Claim 7
Dependent Claim 19 words
The method of claim 1 wherein the hematopoietic cells are derived from peripheral blood or from newborn cord blood.
Claim 8
Dependent Claim 12 words
The method of claim 1 wherein the hematopoietic cell population is allogeneic.
Claim 9
Dependent Claim 12 words
The method of claim 1 wherein the hematopoietic cell population is autologous.
Claim 10
Dependent Claim 15 words
The method of claim 2 wherein the hematopoietic cells consist essentially of natural killer cells.
Claim 11
Dependent Claim 13 words
The method of claim 3 wherein the stem cells are CD34 + .
Claim 12
Dependent Claim 16 words
The method of claim 10 wherein the stem cells are Lin - CD34 +DR - .

References Cited (Backward Citations)

US4883662A Cited
WO1993018137A1 Cited
WO1993020184A1 Cited
US5460964A Cited
WO1995013088A1 Cited
US5523286A Cited
US5605829A Cited
WO1996002662A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-07-12 2003-01-11 2003-07-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-07-12 2007-01-11 2007-07-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-07-12 2011-01-11 2011-07-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag